A late sign-off this evening due to various errands and time spent with the short people. Nonetheless, the world keeps spinning and here are a few items that came our way. And
please remember to vote
in our reader poll (
) about whether an OTC version of the Mevacor cholesterol pill is a good idea...
Amgen, J&J Amgen Drugs Show Higher Leukemia Risk (Bloomberg News)
Celgene Stock Plunges After Disappointing Revlimid Study (Bloomberg News)
Muddled Data Hurts Medarex Shares (TheStreet.com)
Novo Nordisk Settles Patent Dispute With Pfizer (The Guardian/Reuters)